Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Statistics and Information Department. Vital statistics 2014. Ministry of Health, Labor and Welfare http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/kakutei14/index.html (2014).
2. Faris, J. E. et al. FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience. Oncologist. 18, 543–548 (2013).
3. Huxley, R., Ansary-Moghaddam, A., Berrington de Gonzalez, A., Barzi, F. & Woodwad, M. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer. 92, 2076–2083 (2005).
4. Kasuga, M. et al. Report of the Japan Diabetes Society/Japanese Cancer Association Joint Committee on Diabetes and Cancer. Cancer Sci. 104, 965–976 (2013).
5. Chu, C. K. et al. Preoperative diabetes mellitus and long-term survival after resection of pancreatic adenocarcinoma. Ann Surg Oncol. 17, 502–513 (2010).